Header Logo

Connection

ALEXANDER LAZAR to Soft Tissue Neoplasms

Back to Details
This is a "connection" page, showing publications ALEXANDER LAZAR has written about Soft Tissue Neoplasms.
ALEXANDER LAZAR
Connection Strength
6.035
Soft Tissue Neoplasms
  1. PAX7 expression in sarcomas bearing the EWSR1-NFATC2 translocation. Mod Pathol. 2019 01; 32(1):154-156.
    View in: PubMed
    Score: 0.376
  2. Sarcoma Brain Metastases: 28?Years of Experience at a Single Institution. Ann Surg Oncol. 2016 12; 23(Suppl 5):962-967.
    View in: PubMed
    Score: 0.332
  3. Angiosarcoma: a tissue microarray study with diagnostic implications. Am J Dermatopathol. 2013 Jun; 35(4):432-7.
    View in: PubMed
    Score: 0.264
  4. New therapeutic targets in soft tissue sarcoma. Adv Anat Pathol. 2012 May; 19(3):170-80.
    View in: PubMed
    Score: 0.245
  5. Clinicopathologic considerations: how can we fine tune our approach to sarcoma? Semin Oncol. 2011 Oct; 38 Suppl 3:S3-18.
    View in: PubMed
    Score: 0.235
  6. Validation of potential therapeutic targets in alveolar soft part sarcoma: an immunohistochemical study utilizing tissue microarray. Histopathology. 2009 Dec; 55(6):750-5.
    View in: PubMed
    Score: 0.207
  7. Cutaneous and subcutaneous metastases of gastrointestinal stromal tumors: a series of 5 cases with molecular analysis. Am J Dermatopathol. 2009 May; 31(3):297-300.
    View in: PubMed
    Score: 0.199
  8. Sarcoma molecular testing: diagnosis and prognosis. Curr Oncol Rep. 2007 Jul; 9(4):309-15.
    View in: PubMed
    Score: 0.175
  9. Molecular diagnosis of sarcomas: chromosomal translocations in sarcomas. Arch Pathol Lab Med. 2006 Aug; 130(8):1199-207.
    View in: PubMed
    Score: 0.164
  10. Updates on WHO classification for small round cell tumors: Ewing sarcoma vs. everything else. Hum Pathol. 2024 05; 147:101-113.
    View in: PubMed
    Score: 0.138
  11. GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis. Mod Pathol. 2024 Feb; 37(2):100386.
    View in: PubMed
    Score: 0.136
  12. Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma. HGG Adv. 2023 10 12; 4(4):100224.
    View in: PubMed
    Score: 0.133
  13. Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing. BMC Cancer. 2023 May 31; 23(1):488.
    View in: PubMed
    Score: 0.132
  14. Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101). Clin Cancer Res. 2023 05 01; 29(9):1708-1718.
    View in: PubMed
    Score: 0.131
  15. Oesophageal glomus tumours: rare neoplasms with aggressive clinical behaviour. Histopathology. 2023 Jun; 82(7):1048-1055.
    View in: PubMed
    Score: 0.129
  16. Superficial low-grade fibromyxoid sarcoma. J Cutan Pathol. 2023 Feb; 50(2):147-154.
    View in: PubMed
    Score: 0.127
  17. Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas: A Systematic Review of the Literature. Ann Surg Oncol. 2023 Feb; 30(2):958-967.
    View in: PubMed
    Score: 0.127
  18. Frequent TRPS1 expression in synovial sarcoma is associated with SS18-SSX fusion oncoprotein activity. Hum Pathol. 2022 Dec; 130:88-94.
    View in: PubMed
    Score: 0.126
  19. Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Lancet Oncol. 2022 09; 23(9):1156-1166.
    View in: PubMed
    Score: 0.125
  20. Final Safety and Health-Related Quality of LIfe Results of the Phase 2/3 Act.In.Sarc Study With Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma. Int J Radiat Oncol Biol Phys. 2022 11 01; 114(3):422-432.
    View in: PubMed
    Score: 0.124
  21. Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor. Lab Invest. 2022 06; 102(6):658-666.
    View in: PubMed
    Score: 0.121
  22. Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center. Int J Cancer. 2022 06 15; 150(12):2012-2024.
    View in: PubMed
    Score: 0.121
  23. Expression of TRPS1 in phyllodes tumor and sarcoma of the breast. Hum Pathol. 2022 03; 121:73-80.
    View in: PubMed
    Score: 0.120
  24. Synovial Sarcoma of the Hand and Foot: An Institutional Review. Am J Clin Oncol. 2021 07 01; 44(7):361-368.
    View in: PubMed
    Score: 0.116
  25. Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma. Oncologist. 2021 03; 26(3):250-260.
    View in: PubMed
    Score: 0.111
  26. Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. Clin Cancer Res. 2020 03 15; 26(6):1258-1266.
    View in: PubMed
    Score: 0.104
  27. NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial. Lancet Oncol. 2019 08; 20(8):1148-1159.
    View in: PubMed
    Score: 0.101
  28. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol. 2017 11; 18(11):1493-1501.
    View in: PubMed
    Score: 0.089
  29. PAX7 Expression in Rhabdomyosarcoma, Related Soft Tissue Tumors, and Small Round Blue Cell Neoplasms. Am J Surg Pathol. 2016 10; 40(10):1305-15.
    View in: PubMed
    Score: 0.083
  30. Myxofibrosarcoma. Surg Oncol Clin N Am. 2016 10; 25(4):775-88.
    View in: PubMed
    Score: 0.082
  31. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. Ann Surg Oncol. 2016 07; 23(7):2220-8.
    View in: PubMed
    Score: 0.079
  32. Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) and Imaging Group recommendations for radiological examination and reporting with an emphasis on magnetic resonance imaging. Eur J Cancer. 2016 Mar; 56:37-44.
    View in: PubMed
    Score: 0.079
  33. Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature. J Neurooncol. 2016 Mar; 127(1):155-63.
    View in: PubMed
    Score: 0.079
  34. Extensive survey of STAT6 expression in a large series of mesenchymal tumors. Am J Clin Pathol. 2015 May; 143(5):672-82.
    View in: PubMed
    Score: 0.075
  35. NY-ESO-1 (CTAG1B) expression in mesenchymal tumors. Mod Pathol. 2015 Apr; 28(4):587-95.
    View in: PubMed
    Score: 0.073
  36. BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. Mod Pathol. 2015 Apr; 28(4):575-86.
    View in: PubMed
    Score: 0.073
  37. Three-dimensional computational analysis of optical coherence tomography images for the detection of soft tissue sarcomas. J Biomed Opt. 2014 Feb; 19(2):21102.
    View in: PubMed
    Score: 0.069
  38. Noncontact measurement of elasticity for the detection of soft-tissue tumors using phase-sensitive optical coherence tomography combined with a focused air-puff system. Opt Lett. 2012 Dec 15; 37(24):5184-6.
    View in: PubMed
    Score: 0.064
  39. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Am J Surg Pathol. 2012 Oct; 36(10):1444-51.
    View in: PubMed
    Score: 0.063
  40. Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma. Mod Pathol. 2012 Feb; 25(2):212-21.
    View in: PubMed
    Score: 0.059
  41. The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray study. Histopathology. 2011 Sep; 59(3):556-61.
    View in: PubMed
    Score: 0.058
  42. Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target. J Pathol. 2011 Dec; 225(4):574-82.
    View in: PubMed
    Score: 0.058
  43. Liposarcoma in children and young adults: a multi-institutional experience. Pediatr Blood Cancer. 2011 Dec 15; 57(7):1142-6.
    View in: PubMed
    Score: 0.057
  44. Epithelioid sarcoma and unclassified sarcoma with epithelioid features: clinicopathological variables, molecular markers, and a new experimental model. Oncologist. 2011; 16(4):512-22.
    View in: PubMed
    Score: 0.056
  45. Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene. 2011 Jan 27; 30(4):457-70.
    View in: PubMed
    Score: 0.055
  46. Protocol for the examination of specimens from patients with tumors of soft tissue. Arch Pathol Lab Med. 2010 Apr; 134(4):e31-9.
    View in: PubMed
    Score: 0.053
  47. Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts). Mod Pathol. 2009 Sep; 22(9):1201-9.
    View in: PubMed
    Score: 0.050
  48. Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target. Clin Cancer Res. 2008 Aug 15; 14(16):5033-42.
    View in: PubMed
    Score: 0.047
  49. Genetic aberrations in soft tissue leiomyosarcoma. Cancer Lett. 2009 Mar 08; 275(1):1-8.
    View in: PubMed
    Score: 0.047
  50. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma. Mod Pathol. 2008 Nov; 21(11):1303-10.
    View in: PubMed
    Score: 0.047
  51. Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation. Mol Cancer Ther. 2007 May; 6(5):1650-60.
    View in: PubMed
    Score: 0.043
  52. Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group. ESMO Open. 2024 Sep; 9(9):103689.
    View in: PubMed
    Score: 0.036
  53. Radiation-associated sarcomas other than malignant peripheral nerve sheath tumours demonstrate loss of histone H3K27 trimethylation?. Histopathology. 2021 Jan; 78(2):321-326.
    View in: PubMed
    Score: 0.027
  54. Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma. PLoS One. 2009 Nov 30; 4(11):e8075.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.